Bioimpedance Analyzers Market

The global bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. Growth in this market is attributed to the increase in the prevalence of obesity, diabetes, a sedentary lifestyle, and an increasing number of health clubs.

The bioimpedance analyzers market is competitive and is dominated by various players. The major players operating in this market are OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), and Seca GmbH & Co. KG (Germany). These include product launches, contracts, partnerships, mergers and acquisitions, and new product development activities to further expand their presence in the bioimpedance analyzers market.

To know about the assumptions considered for the study download the pdf brochure

OMRON CORPORATION

OMRON Corporation is the second-leading player in the bioimpedance analyzers market. The company has a strong presence in Japan, Greater China, the Americas, Europe, and Southern Asia, among other regions, as well as numerous subsidiaries and distribution channels. OMRON generated ~19% of its total revenue from Japan in 2022. The company’s strong investments in innovative products have helped it become a reputed player in bioimpedance analyzers.

TANITA CORPORATION

Tanita Corporation is the leading player in the bioimpedance analyzers market. The company is present in the US, China, India, Hong Kong, and Europe. It partners with major domestic and export companies to develop products through extensive clinical research. The company’s strong heritage of technology, leadership, and innovation has provided a solid foundation for the continued development of safe and cost-effective products.

INBODY CO., LTD.

InBody is a well-established and prominent player in the bioimpedance analyzers market. It offers a wide range of products and has a strong global presence, mainly due to its excellent distribution channel. The company’s global footprint and the critical nature of its products play a key role in expanding access to healthcare in emerging and developed countries. The company mainly adopts organic and inorganic strategies, such as product launches and partnerships, to maintain its position in this market. For instance, in 2023, the company partnered with iLoveKickboxing.

Related Reports:

Bioimpedance Analyzers Market by Type (Single, Multi & Dual Frequency), Modality (Wired, Wireless), Application (Segmental Body Measurement, Whole Body Measurement), End User (Fitness Clubs, Home Users, Hospitals), & Region- Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com